Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 51
Filter
9.
Int J Rheum Dis ; 20(12): 2086-2092, 2017 Dec.
Article in English | MEDLINE | ID: mdl-24860912

ABSTRACT

AIM: The aim of this study is to analyze possible autonomic nerve system alterations and assess the efficacy of heart rate variability (HRV) analysis in anticipation of cardiovascular risks in pediatric patients with familial Mediterranean fever (FMF). METHOD: In this study, cardiac autonomic functions were investigated in children with FMF by analyzing HRV and its other probable cardiac effects by echocardiography. We studied 70 pediatric patients with FMF and 50 healthy controls. RESULTS: The time-domain parameters of HRV were compared between the FMF and control groups. SDNN (standard deviation of all NN intervals) was significantly decreased in patients with FMF as compared to control subjects. The other time-domain parameters of HRV and the frequency-domain parameters of HRV were similar in both groups. Frequency-dependent HRV parameters were similar in both groups, as were conventional echocardiographic parameters. CONCLUSION: HRV is a convenient and reliable technique for evaluation of autonomic functions. There are only a few studies on the assessment of autonomic functions by means of HRV in adult FMF patients but not in pediatric patients. Further studies are required to assess whether there is autonomic dysfunction in children with FMF.


Subject(s)
Autonomic Nervous System/physiopathology , Familial Mediterranean Fever/physiopathology , Heart Rate , Heart/innervation , Adolescent , Cardiovascular Diseases/etiology , Cardiovascular Diseases/physiopathology , Case-Control Studies , Child , Echocardiography , Electrocardiography, Ambulatory , Familial Mediterranean Fever/complications , Familial Mediterranean Fever/diagnosis , Female , Humans , Male , Predictive Value of Tests , Risk Factors , Time Factors
13.
Arq. bras. cardiol ; 107(6): 600-604, Dec. 2016. graf
Article in English | LILACS | ID: biblio-838664

ABSTRACT

Abstract Extracorporeal membrane oxygenation (ECMO) is a well-established tool of cardiopulmonary circulatory support for cardiopulmonary failure in children and adults. It has been used as a supportive strategy during interventional procedures in neonates with congenital heart disease. Herein, we describe a neonate with hypoplastic left heart syndrome who underwent stenting of the Sano shunt and left pulmonary artery after Norwood Sano operation using intra-procedural ECMO support. The use of ECMO as a bridge to recovery might be a feasible and reasonably safe adjunctive approach in the treatment of complications in selective case of neonates having undergone the Norwood Sano procedure.


Resumo A oxigenação por membrana extracorpórea (ECMO) é uma ferramenta bem estabelecida de suporte circulatório em casos de insuficiência em crianças e adultos. A ECMO tem sido utilizada como uma estratégia de suporte durante procedimentos interventistas em recém-nascidos com doença cardíaca congênita. Descrevemos o caso de um recém-nascido com síndrome do coração esquerdo hipoplásico que foi submetido à colocação de um stent em shunt de Sano e artéria pulmonar esquerda após procedimento de Norwood-Sano utilizando-se a ECMO como suporte. O uso da ECMO pode ser uma estratégia adjunta viável e segura no tratamento de complicações em casos eletivos de recém-nascidos submetidos à operação de Norwood-Sano.


Subject(s)
Humans , Male , Arteriovenous Shunt, Surgical/methods , Extracorporeal Membrane Oxygenation/methods , Stents , Hypoplastic Left Heart Syndrome/surgery , Norwood Procedures/methods , Pulmonary Artery/surgery , Angiography/methods , Reproducibility of Results , Treatment Outcome , Prosthesis Implantation/methods
17.
Pacing Clin Electrophysiol ; 39(11): 1225-1239, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27620455

ABSTRACT

BACKGROUND: Despite concerns about complications with the implantable cardioverter defibrillator (ICD), it is effective for the prevention of sudden cardiac death (SCD). We aimed to analyze our midterm experience with ICD in children and young adults. METHODS: This retrospective study included patients who were implanted with an ICD between 2001 and 2014. Demographic characteristics, clinical information, shock features, and complications for all patients with ICD were analyzed. The study population was divided into two groups: early-era patients implanted before 2008, and late-era patients implanted after 2008. RESULTS: Sixty-nine patients (median age: 12 years, median follow-up: 52 months) were implanted with an ICD. Diagnostic categories were channelopathy (56.6%), cardiomyopathy (36.2%), congenital heart disease (5.8%), and other (1.4%). We performed implantation for primary prevention in 66.6% (39.3% in early-era patients and 85.4% in late-era patients). Thirty-one (44.9%) received 139 appropriate shocks (66% of total shocks) while 14 (20.2%) received 71 inappropriate shocks. However, there was no statistically significant difference in the use of appropriate shocks in the primary (66.7%) versus the secondary (72.2%) prevention groups. The incidence of appropriate and inappropriate shock was 66.7% and 33.3% in the primary prevention group, and 72.2% and 27.8% in the secondary prevention group, respectively. Two patients died, although only one death was the result of a lead problem. CONCLUSIONS: Although lead integrity problems, inappropriate shocks, and infections are significant issues, ICD therapy appears to be a safe, effective, and necessary option for the prevention of SCD in both children and young adults.


Subject(s)
Defibrillators, Implantable , Adolescent , Adult , Cardiomyopathies/therapy , Channelopathies/therapy , Child , Child, Preschool , Death, Sudden, Cardiac/prevention & control , Defibrillators, Implantable/adverse effects , Female , Heart Defects, Congenital/therapy , Humans , Infant , Male , Retrospective Studies , Treatment Outcome , Turkey , Young Adult
18.
J Infect Chemother ; 22(9): 617-21, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27400951

ABSTRACT

AIM OF STUDY: Neutropenic fever is a source of morbidity and mortality in children with cancer. It is not possible to detect the causative agent in cultures in most cases; the research for a marker that can show the severity of the disease is ongoing. We evaluated the role of adrenomedullin (ADM) at predicting prognosis on patients with febrile neutropenia, which has been proven to be a good prognostic marker for diseases with high morbidity and mortality, such as heart failure, ischemic ventricular dysfunction, sepsis, and systemic inflammatory response syndrome. MATERIALS AND METHODS: We recorded the 36 febrile episodes of 14 children receiving chemotherapy due to solid tumors. There were 10 events with unknown origin in the low-risk group, while in the high-risk group, there were 17 events with unknown origin, 8 events with microbiological origin and 1 event with clinically proven infection. Cultures were positive only in the high-risk group. However, the changes of ADM levels through time periods (first, second, third, and seventh days) were not significant. RESULTS: The first-day plasma ADM levels significantly predicted the presence of culture positivity (AUC 0.628, 95% CI 0.40-0.85, p = 0.303) and high-risk patients with neutropenic fever (AUC 0.76, 95% CI 0.56-0.97, p = 0.016). CONCLUSION: Our study showed that increased plasma ADM was correlated with high-risk neutropenic fever and culture positivity. The ADM levels in the high-risk group were clearly high at the diagnosis and continued to the end of the treatment.


Subject(s)
Adrenomedullin/blood , Febrile Neutropenia/blood , Neoplasms/complications , Adolescent , Anti-Bacterial Agents/therapeutic use , Biomarkers/blood , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Febrile Neutropenia/drug therapy , Febrile Neutropenia/microbiology , Fever of Unknown Origin/blood , Fever of Unknown Origin/drug therapy , Fever of Unknown Origin/microbiology , Humans , Prognosis , Sensitivity and Specificity , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...